Incyte | INCY - Trade Debtors

Stock Price
101.26
Daily Change
1.17 1.17%
Monthly
0.08%
Yearly
37.77%
Q1 Forecast
98.18

Incyte reported $1.02B in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
Acadia Pharmaceuticals USD 148.23M 8.79M Dec/2025
Agenus USD 354K 53K Mar/2025
Agios Pharmaceuticals USD 10.58M 5.55M Dec/2025
Alnylam Pharmaceuticals USD 777.57M 187.2M Dec/2025
Amgen USD 9.57B 1.08B Dec/2025
BioCryst Pharmaceuticals USD 79.07M 6.61M Dec/2024
Biogen USD 1.85B 234M Sep/2025
BioMarin Pharmaceutical USD 908.21M 117.95M Dec/2025
Bristol-Myers Squibb USD 14.62B 485M Sep/2025
Eli Lilly USD 19.46B 2.25B Sep/2025
Exelixis USD 286.92M 24.38M Dec/2025
Gilead Sciences USD 4.91B 182M Dec/2025
Incyte USD 1.02B 128.52M Dec/2025
Ionis Pharmaceuticals USD 66M 41.39M Dec/2025
MacroGenics USD 69.23M 56.7M Sep/2025
Merck USD 12.12B 596M Sep/2025
Moderna USD 184M 862M Dec/2025
Nektar Therapeutics USD 0 2.9M Sep/2024
Neurocrine Biosciences USD 686.8M 41.2M Dec/2025
Novartis USD 8.98B 192M Sep/2025
Novartis USD 8.98B 192M Sep/2025
Pfizer USD 18.12B 2.02B Sep/2025
PTC Therapeutics USD 181.62M 21.45M Dec/2025
Puma Biotechnology USD 28.1M 3.52M Jun/2024
Regeneron Pharmaceuticals USD 5.74B 54M Dec/2025
Sarepta Therapeutics USD 398.23M 2.49M Dec/2025
Ultragenyx Pharmaceutical USD 112.54M 11.92M Sep/2025
Vertex Pharmaceuticals USD 2.05B 106.4M Dec/2025